Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

NASDAQ:NTLA

Intellia Therapeutics (NTLA)

15.62
-0.05 (0.32%)
as of Jun 18, 2026, 11:57:56 pm Market Open.
0 watching
0
COMMENT
Announced positive early results in gene-editing that would treat a rare genetic disease that impacts 50,000 people. Shares shot up 50% today. Regeneron is their partner. Cathy Wood heavily invests in these stocks.
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Intellia Therapeutics (NTLA) Frequently Asked Questions

What is Intellia Therapeutics stock symbol?

Intellia Therapeutics is a American stock, trading under the symbol NTLA (previously NTLA-Q on Stockchase) on the NASDAQ (NTLA). It is usually referred to as NASDAQ:NTLA or NTLA

Is Intellia Therapeutics a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on NTLA (previously NTLA-Q on Stockchase) on Stockchase. Read the latest expert commentary for Intellia Therapeutics.

Is Intellia Therapeutics a good investment or a top pick?

Intellia Therapeutics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Intellia Therapeutics.

Why is Intellia Therapeutics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Intellia Therapeutics.

Is Intellia Therapeutics worth watching?

Intellia Therapeutics is covered by Stockchase experts and is worth watching.

What is Intellia Therapeutics stock price?

On 2026-06-18, Intellia Therapeutics (NTLA) stock closed at a price of $15.62.